Gastric Cancer Therapy
Researchers at Seoul National University, Department of Internal Medicine target gastric cancer therapy
Published in Hospital Law Weekly, April 16th, 2009
New investigation results, 'Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling,' are detailed in a study published in Journal of Gastroenterology and Hepatology. According to recent research from Seoul, South Korea, "Previously, we showed that treatment with celecoxib significantly reduced the number of viable gastric cancer cells, in a dose-and time-dependent manner. However, the specific anti-cancer effects of celecoxib on gastric cancer cells have not been clarified."
"The present in vitro study was carried out to investigate the mechanism involved in the anti-gastric cancer effects of celecoxib....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2009-04-16)
More Articles from Hospital Law Weekly
- Ambulatory Surgery
Medical Web Technologies Enables Ambulatory Surgery Centers to Meet New CMS Regulatory Guidelines on Patient Rights - Appriss Inc.
Free Training Designed to Educate the Public About VINE - Childbirth Connection
Childbirth Connection to Present Inaugural Maternity Care Quality Award to Seton Family of Hospitals - Community Health Systems, Inc.
Community Health Systems, Inc. Announces the Divestiture of Denton, Texas Hospital to Joint Venture Partner - CVS Caremark
Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions - Diagnostics
Coalition for 21st Century Medicine Endorses 'Patient Access to Critical Lab Tests Act' - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
